At a glance: Wasp venom allergy

Oedema, erythema and pain at the site of the sting develops over hours and settles within a few days
Oedema, erythema and pain at the site of the sting develops over hours and settles within a few days

Epidemiology  

Sensitisation to wasp venom can occur after a single sting.  

Most common in the late summer and early autumn.  

Clinical features  

Oedema, erythema and pain at the site of the sting which is a non-allergic reaction to the venom. This usually develops over hours and settles within a few days.  

May cause blistering and secondary infection.  

Mild reactions result in urticaria, pruritis and/or angio-oedema.  

More severe reactions may cause anaphylaxis and can develop within 10 minutes.  

Investigations  

Wasp specific IgE (RAST) or skin-prick testing.  

Management 

Oral antihistamines for local reactions, with steroids reserved for more severe localised reactions  

Adrenaline IM if any life-threatening features and systemic steroids.  

Advice on avoidance.  

Immunotherapy is effective and should be considered in patients with a history of severe generalised reactions.  

Advice on avoiding wasp stings includes avoiding walking barefooted on grass, avoiding orchards, and not drinking directly from a can.  

Contributed by Dr Sangeeta Dhami, GP Locum, Edinburgh, and Professor Aziz Sheikh, division of community health sciences, University of Edinburgh  

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GPs unlikely to begin COVID-19 vaccination for 'at least two weeks', says BMA

GPs unlikely to begin COVID-19 vaccination for 'at least two weeks', says BMA

GP practices are unlikely to receive stocks of COVID-19 vaccine 'for at least another...

JCVI confirms priority groups for COVID-19 vaccination

JCVI confirms priority groups for COVID-19 vaccination

The Joint Committee on Vaccination and Immunisation (JCVI) has published a final...

MHRA approves Pfizer/BioNTech jab paving way for COVID-19 vaccination to start

MHRA approves Pfizer/BioNTech jab paving way for COVID-19 vaccination to start

The MHRA has approved the Pfizer/BioNTech COVID-19 vaccine for use in the UK and...

Enhanced service contract for GP practices delivering COVID-19 vaccine revealed

Enhanced service contract for GP practices delivering COVID-19 vaccine revealed

GP practices have until midnight on 7 December to sign up to a COVID-19 enhanced...

Five GP practices a week inspected by CQC during pandemic second wave

Five GP practices a week inspected by CQC during pandemic second wave

The CQC has inspected five GP practices a week in England since the second wave of...

Pregnant women and under-18s will not be offered COVID-19 vaccine

Pregnant women and under-18s will not be offered COVID-19 vaccine

Pregnant women, children and under-18s will not be recommended for routine COVID-19...